Everyday, there are probably some retail sellers who bought 1's earlier and now want out because they can't afford to, or don't want to, wait any longer for profits.
However, as I recently pointed out, DNA management likely can only get funding for their new product by selling new shares into the market. Yup, that means dilution. As long as the dilution gets the company another roll of the dice in the marketplace with a new product, I am happy and have no problem supporting the company's actions.